Elekta and its global collaborators overcame significant engineering hurdles to demonstrate the technology’s feasibility. Previously, experts in the field thought it nearly impossible to combine MRI ...

STOCKHOLM, March 8, 2019 /PRNewswire/ -- With the number of new cancer cases globally expected to rise by about 70 percent over the next two decades1-2, access to radiotherapy – a key treatment ...

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Elekta (EKTA-B.ST) and Royal Philips (NYSE:PHG, AEX:PHIA) today announced the installation of a third high-field (1.5 Tesla) MR-guided linear accelerator ...

Radiation therapy system delivered to Korea's Hallym University Kangnam Sacred Heart Hospital STOCKHOLM, March 8, 2019 /PRNewswire/ -- With the number of new cancer cases globally expected to rise by ...

Multiple presentations highlight clinical potential of MR-linac in a variety of cancers and demonstrate the need to address intra-session motion BOSTON, September 29, 2016 – Elekta (EKTA-B.ST) today ...

Research to focus on the use of MR-adapted radiotherapy in patients with lung cancer Regulatory News: Elekta (EKTA-B.ST), its MRI technology partner Royal Philips (NYSE: PHG, AEX: PHIA) and The ...

The University of Texas MD Anderson Cancer Center, Elekta and Philips teams recently completed installation of the first high field (1.5 Tesla) MRI-guided linear accelerator in the United States. By ...

ATLANTA — With much pomp and circumstance, Elekta (Stockholm, Sweden) unveiled its Versa HD, an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of ...

BARCELONA, Spain, Sept. 10 Elekta today unveiled a newmember of the Elekta family of linear accelerators at the European Society ofTherapeutic Radiation Oncologists (ESTRO) 2007 meeting. At an 11 ...

Through the collaboration with Elekta and the consortium partners such as The NKI, I am convinced that we have the prerequisites to make MR-guided radiotherapy a meaningful success for both patients ...